Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedNew navigation/help sections were added to the study details page (How to Read a Study Record, Common Questions, How to Join a Study) along with new metadata fields (Last verified, Last known status was). The page revision label was updated from v3.5.5 to v3.6.0 to reflect these changes.SummaryDifference2%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page’s metadata. It reflects an incremental revision in the page’s version history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating an updated version of the page content. This appears to be a minor revision note rather than a substantive update to study details.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, representing a small update to the study page without substantive content changes.SummaryDifference0.1%

- Check58 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check73 days agoChange DetectedAdrenal cortex carcinoma added as a keyword/MeSH term on the study page.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.